Host- and strain-specific regulation of influenza virus polymerase activity by interacting cellular proteins

mBio

Volumn 2, Issue 4, 2011, Pages

  Bortz, Eric ^a   Westera, Liset ^b   Maamary, Jad ^a   Steel, John ^a,c   Albrecht, Randy A ^a   Manicassamy, Balaji ^a   Chase, Geoffrey ^d   Martínez Sobrido, Luis ^e   Schwemmle, Martin ^d   García Sastrea, Adolfo ^a,f  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF FREIBURG   (Germany)

^e UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^f Division of Infectious Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; DDB1 PROTEIN; DDX17 PROTEIN; DDX5 PROTEIN; DEAD BOX PROTEIN; INTERLEUKIN ENHANCER BINDING FACTOR 3; KU ANTIGEN; KU86 PROTEIN; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NUCLEOPHOSMIN; NXP2 PROTEIN; PROTEIN P72; RNA DIRECTED RNA POLYMERASE; RNPM PROTEIN; UNCLASSIFIED DRUG; VIRUS RNA;

ARTICLE; CHICKEN; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME SPECIFICITY; FIBROBLAST; FUNCTIONAL GENOMICS; GENOTYPE; HUMAN; HUMAN CELL; INFLUENZA VIRUS; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H5N1; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; RNA SYNTHESIS; VIRUS CELL INTERACTION; VIRUS STRAIN;

AVES; INFLUENZA A VIRUS; MAMMALIA; ORTHOMYXOVIRIDAE;

EID: 80052576674     PISSN: None     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00151-11     Document Type: Article

References (47)

1. Neumann G, Chen H, Gao GF, Shu Y, Kawaoka Y. 2010. H5N1 influenza viruses: outbreaks and biological properties. Cell Res. 20:51-61.
2. Smith GJ, et al. 2006. Emergence and predominance of an H5N1 influenza variant in China. Proc. Natl. Acad. Sci. U. S. A. 103:16936-16941.
3. Wan XF, et al. 2008. Evolution of highly pathogenic H5N1 avian influenza viruses in Vietnam between 2001 and 2007. PLoS One 3:e3462.
4. Gao R, et al. 2010. A systematic molecular pathology study of a laboratory confirmed H5N1 human case. PLoS One 5:e13315.
5. Hatta M, Neumann G, Kawaoka Y. 2001. Reverse genetics approach towards understanding pathogenesis of H5N1 Hong Kong influenza A virus infection. Philos. Trans. R. Soc. Lond. B Biol. Sci. 356:1841-1843.
6. Maines TR, et al. 2005. Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals. J. Virol. 79:11788-11800.
7. Salomon R, et al. 2006. The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04. J. Exp. Med. 203:689-697.
8. Gabriel G, Herwig A, Klenk HD. 2008. Interaction of polymerase subunit PB2 and NP with importin alpha1 is a determinant of host range of influenza A virus. PLoS Pathog. 4:e11.
9. Rolling T, et al. 2009. Adaptive mutations resulting in enhanced polymerase activity contribute to high virulence of influenza A virus in mice. J. Virol. 83:6673-6680.
10. Li J, et al. 2009. Single mutation at the amino acid position 627 of PB2 that leads to increased virulence of an H5N1 avian influenza virus during adaptation in mice can be compensated by multiple mutations at other sites of PB2. Virus Res. 144:123-129.
11. Yamada S, et al. 2010. Biological and structural characterization of a host-adapting amino acid in influenza virus. PLoS Pathog. 6:e1001034.
12. Hatta M, Gao P, Halfmann P, Kawaoka Y. 2001. Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 293: 1840-1842.
13. Steel J, Lowen AC, Mubareka S, Palese P. 2009. Transmission of influenza virus in a mammalian host is increased by PB2 amino acids 627K or 627E/701N. PLoS Pathog. 5:e1000252.
14. Le QM, Sakai-Tagawa Y, Ozawa M, Ito M, Kawaoka Y. 2009. Selection of H5N1 influenza virus PB2 during replication in humans. J. Virol. 83: 5278-5281.
15. Deng T, et al. 2006. Role of Ran binding protein 5 in nuclear import and assembly of the influenza virus RNA polymerase complex. J. Virol. 80: 11911-11919.
16. Honda A, Okamoto T, Ishihama A. 2007. Host factor Ebp1: selective inhibitor of influenza virus transcriptase. Genes Cells 12:133-142.
17. Jorba N, et al. 2008. Analysis of the interaction of influenza virus polymerase complex with human cell factors. Proteomics 8:2077-2088.
18. Mayer D, et al. 2007. Identification of cellular interaction partners of the influenza virus ribonucleoprotein complex and polymerase complex using proteomic-based approaches. J. Proteome Res. 6:672-682.
19. Momose F, et al. 2001. Cellular splicing factor RAF-2p48/NPI-5/BAT1/ UAP56 interacts with the influenza virus nucleoprotein and enhances viral RNA synthesis. J. Virol. 75:1899-1908.
20. Momose F, et al. 2002. Identification of Hsp90 as a stimulatory host factor involved in influenza virus RNA synthesis. J. Biol. Chem. 277: 45306-45314.
21. Naito T, et al. 2007. An influenza virus replicon system in yeast identified Tat-SF1 as a stimulatory host factor for viral RNA synthesis. Proc. Natl. Acad. Sci. U. S. A. 104:18235-18240.
22. Wang P, et al. 2009. Nuclear factor 90 negatively regulates influenza virus replication by interacting with viral nucleoprotein. J. Virol. 83: 7850-7861.
23. Chase G, et al. 2008. Hsp90 inhibitors reduce influenza virus replication in cell culture. Virology 377:431-439.
24. Brass AL, et al. 2009. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139: 1243-1254.
25. Karlas A, et al. 2010. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 463:818-822.
26. König R, et al. 2010. Human host factors required for influenza virus replication. Nature 463:813-817.
27. Shapira SD, et al. 2009. A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 139:1255-1267.
28. Amorim MJ, Read EK, Dalton RM, Medcalf L, Digard P. 2007. Nuclear export of influenza A virus mRNAs requires ongoing RNA polymerase II activity. Traffic 8:1-11.
29. Hoffmann HH, Palese P, Shaw ML. 2008. Modulation of influenza virus replication by alteration of sodium ion transport and protein kinase C activity. Antiviral Res. 80:124-134.
30. Lee JH, et al. 2010. Direct interaction of cellular hnRNP-F and NS1 of influenza A virus accelerates viral replication by modulation of viral transcriptional activity and host gene expression. Virology 397:89-99.
31. Elton D, et al. 2001. Interaction of the influenza virus nucleoprotein with the cellular CRM1-mediated nuclear export pathway. J. Virol. 75: 408-419.
32. Burgui I, Aragón T, Ortín J, Nieto A. 2003. PABP1 and eIF4GI associatewith influenza virus NS1 protein in viral mRNA translation initiation complexes. J. Gen. Virol. 84:3263-3274.
33. Watanabe T, Watanabe S, Kawaoka Y. 2010. Cellular networks involved in the influenza virus life cycle. Cell Host Microbe 7:427-439.
34. Squires B, et al. 2008. BioHealthBase: informatics support in the elucidation of influenza virus host pathogen interactions and virulence. Nucleic Acids Res. 36:D497-D503.
35. Elton D, Amorim MJ, Medcalf L, Digard P. 2005. Genome gating"; polarized intranuclear trafficking of influenza virus RNPs.Biol. Lett. 1:113-117.
36. Momose F, et al. 2011. Apical transport of influenza A virus ribonucleoprotein requires Rab11-positive recycling endosome. PLoS One 6:e21123.
37. Moncorge O, Mura M, Barclay WS. 2010. Evidence for avian and human host cell factors that affect the activity of influenza virus polymerase. J. Virol. 84:9978-9986.
38. Gabriel G, et al. 2011. Differential use of importin-alpha isoforms governs cell tropism and host adaptation of influenza virus. Nat. Commun. 2:156.
39. Ogilvie VC, et al. 2003. The highly related DEAD box RNA helicases p68 and p72 exist as heterodimers in cells. Nucleic Acids Res. 31: 1470-1480.
40. Rössler OG, Straka A, Stahl H. 2001. Rearrangement of structured RNA via branch migration structures catalysed by the highly related DEAD-box proteins p68 and p72. Nucleic Acids Res. 29:2088-2096.
41. Jalal C, Uhlmann-Schiffler H, Stahl H. 2007. Redundant role of DEAD box proteins p68 (Ddx5) and p72/p82 (Ddx17) in ribosome biogenesis and cell proliferation. Nucleic Acids Res. 35:3590-3601.
42. Mehle A, Doudna JA. 2008. An inhibitory activity in human cells restricts the function of an avian-like influenza virus polymerase. Cell Host Microbe 4:111-122.
43. Murdoch K, Loop S, Rudt F, Pieler T. 2002. Nuclear export of 5S rRNA-containing ribonucleoprotein complexes requires CRM1 and the RanGTPase cycle. Eur. J. Cell Biol. 81:549-556.
44. Yu Y, et al. 2006. Nucleophosmin is essential for ribosomal protein L5 nuclear export. Mol. Cell. Biol. 26:3798-3809.
45. Haney SA. 2007. Increasing the robustness and validity of RNAi screens. Pharmacogenomics 8:1037-1049.
46. Steel J, et al. 2009. Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza. J. Virol. 83:1742-1753.
47. Huang DW, Sherman BT, Lempicki RA. 2009. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4:44-57.